|
1
|
Vose J, Armitage J and Weisenburger D;
International T-Cell Lymphoma Project. International peripheral
T-cell and natural killer/T-cell lymphoma study: pathology findings
and clinical outcomes. J Clin Oncol. 26:4124–4130. 2008.
|
|
2
|
Escalón MP, Liu NS, Yang Y, et al:
Prognostic factors and treatment of patients with T-cell
non-Hodgkin lymphoma: the M.D. Anderson Cancer Center experience.
Cancer. 103:2091–2098. 2005.
|
|
3
|
Martin DN, Mikhail IS and Landgren O:
Autoimmunity and hematologic malignancies: associations and
mechanisms. Leuk Lymphoma. 50:541–550. 2009.
|
|
4
|
Hashimoto T: Recent advances in the study
of the pathophysiology of pemphigus. Arch Dermatol Res. 295(Suppl
1): S2–S11. 2003.
|
|
5
|
Yeh SW, Ahmed B, Sami N and Razzaque Ahmed
A: Blistering disorders: diagnosis and treatment. Dermatol Ther.
16:214–223. 2003.
|
|
6
|
Hashimoto T: Immunopathology of IgA
pemphigus. Clin Dermatol. 19:683–689. 2001.
|
|
7
|
Hashimoto T, Kiyokawa C, Mori O, et al:
Human desmocollin 1 (Dsc1) is an autoantigen for the subcorneal
pustular dermatosis type of IgA pemphigus. J Invest Dermatol.
109:127–131. 1997.
|
|
8
|
Hashimoto T, Komai A, Futei Y, Nishikawa T
and Amagai M: Detection of IgA autoantibodies to desmogleins by an
enzyme-linked immunosorbent assay: the presence of new minor
subtypes of IgA pemphigus. Arch Dermatol. 137:735–738. 2001.
|
|
9
|
Amagai M, Komai A, Hashimoto T, et al:
Usefulness of enzyme-linked immunosorbent assay using recombinant
desmogleins 1 and 3 for serodiagnosis of pemphigus. Br J Dermatol.
140:351–357. 1999.
|
|
10
|
Ebihara T, Hashimoto T, Iwatsuki K, et al:
Autoantigens for IgA anti-intercellular antibodies of intercellular
IgA vesiculopustular dermatosis. J Invest Dermatol. 97:742–745.
1991.
|
|
11
|
Beutner EH, Chorzelski TP, Wilson RM, et
al: IgA pemphigus foliaceus. Report of two cases and a review of
the literature. J Am Acad Dermatol. 20:89–97. 1989.
|
|
12
|
Watanabe H, Okada M, Kaji Y, et al: New
response evaluation criteria in solid tumours-revised RECIST
guideline (version 1.1). Gan To Kagaku Ryoho. 36:2495–2501.
2009.(In Japanese).
|
|
13
|
Petropoulou H, Politis G, Panagakis P,
Hatziolou E, Aroni K and Kontochristopoulos G: Immunoglobulin A
pemphigus associated with immunoglobulin A gammopathy and lung
cancer. J Dermatol. 35:341–345. 2008.
|
|
14
|
Szturz P, Adam Z, Klincová M, et al:
Multiple myeloma associated IgA pemphigus: treatment with
bortezomib- and lenalidomide-based regimen. Clin Lymphoma Myeloma
Leuk. 11:517–520. 2011.
|
|
15
|
Taintor AR, Leiferman KM, Hashimoto T,
Ishii N, Zone JJ and Hull CM: A novel case of IgA paraneoplastic
pemphigus associated with chronic lymphocytic leukemia. J Am Acad
Dermatol. 56(5 Suppl): S73–S76. 2007.
|
|
16
|
Asahina A, Koga H, Suzuki Y and Hashimoto
T: IgA pemphigus associated with diffuse large B-cell lymphoma
showing unique reactivity with desmocollins: unusual clinical and
histopathological features. Br J Dermatol. 168:224–226. 2013.
|
|
17
|
Oxberry SG and Johnson MJ: Response to
thalidomide in chemotherapy-resistant cutaneous T-cell lymphoma.
Clin Oncol (R Coll Radiol). 18:86–87. 2006.
|
|
18
|
Herth I, Witzens-Harig M, Beckhove P, et
al: Thalidomide maintenance therapy maturates the T cell
compartment and compromises antigen-specific antitumor immunity in
patients with multiple myeloma. Exp Hematol. 41:231–240. 2013.
|
|
19
|
Kozako T: New treatment strategy for adult
T-cell leukemia targeting for anti-tumor immunity and a longevity
gene-encoded protein. Yakugaku Zasshi. 131:1061–1072. 2011.(In
Japanese).
|
|
20
|
Camisa C and Warner M: Treatment of
pemphigus. Dermatol Nurs. 10:115–118. 123–131. 1998.
|
|
21
|
Gruss C, Zillikens D, Hashimoto T, et al:
Rapid response of IgA pemphigus of subcorneal pustular dermatosis
type to treatment with isotretinoin. J Am Acad Dermatol.
43:923–926. 2000.
|
|
22
|
Ruiz-Genao DP, Hernández-Núñez A,
Hashimoto T, Amagai M, Fernández-Herrera J and García-Díez A: A
case of IgA pemphigus successfully treated with acitretin. Br J
Dermatol. 147:1040–1042. 2002.
|
|
23
|
Howell SM, Bessinger GT, Altman CE and
Belnap CM: Rapid response of IgA pemphigus of the subcorneal
pustular dermatosis subtype to treatment with adalimumab and
mycophenolate mofetil. J Am Acad Dermatol. 53:541–543. 2005.
|
